Strattera (atomoxetine)
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
ADHD NOS
Conditions
ADHD NOS
Trial Timeline
Dec 1, 2003 → Jul 1, 2008
NCT ID
NCT00181766About Strattera (atomoxetine)
Strattera (atomoxetine) is a approved stage product being developed by Eli Lilly for ADHD NOS. The current trial status is completed. This product is registered under clinical trial identifier NCT00181766. Target conditions include ADHD NOS.
What happened to similar drugs?
9 of 20 similar drugs in ADHD NOS were approved
Approved (9) Terminated (3) Active (10)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00181766 | Approved | Completed |
Competing Products
20 competing products in ADHD NOS